Search Results - "Filloon, T G"

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial by GRANGER, Christopher B, MAHAFFEY, Kenneth W, ARMSTRONG, Paul W, WEAVER, W. Douglas, THEROUX, Pierre, HOCHMAN, Judith S, FILLOON, Thomas G, ROLLINS, Scott, TODARO, Thomas G, NICOLAU, Jose C, RUZYLLO, Witold

“…Complement, activated during myocardial ischemia and reperfusion, causes myocardial damage through multiple processes. The COMplement inhibition in Myocardial…”
Get full text

Benzene and leukemia. An epidemiologic risk assessment by Rinsky, R A, Smith, A B, Hornung, R, Filloon, T G, Young, R J, Okun, A H, Landrigan, P J

“…To assess quantitatively the association between benzene exposure and leukemia, we examined the mortality rate of a cohort with occupational exposure to…”
Get more information

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial by MAHAFFEY, Kenneth W, GRANGER, Christopher B, ARMSTRONG, Paul W, NICOLAU, Jose C, RUZYLLO, Witold, WEAVER, W. Douglas, THEROUX, Pierre, HOCHMAN, Judith S, FILLOON, Thomas G, MOJCIK, Christopher F, TODARO, Thomas G

“…Complement activation mediates myocardial damage that occurs during ischemia and reperfusion through multiple pathways. We performed 2 separate, parallel,…”
Get full text

Olestra consumption is not associated with macular pigment optical density in a cross-sectional volunteer sample in Indianapolis by Cooper, D A, Curran-Celentano, J, Ciulla, T A, Hammond, Jr, B R, Danis, R B, Pratt, L M, Riccardi, K A, Filloon, T G

“…The associations between the intake of the fat-substitute olestra and the concentrations of macular carotenoid pigments and serum lutein and zeaxanthin were…”
Get more information

Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing Olestra or triglycerides : A 6-week randomized, placebo-controlled trial by SANDLER, R. S, ZORICH, N. L, FILLOON, T. G, WISEMAN, H. B, LIETZ, D. J, BROCK, M. H, ROYER, M. G, MIDAY, R. K

“…Olestra is a nonabsorbable, energy-free fat substitute. Because it is not absorbed, it may cause digestive symptoms when consumed in large amounts. To compare…”
Get full text

Improving the sensitivity of in vitro skin penetration experiments by KASTING, G. B, FILLOON, T. G, FRANCIS, W. R, MEREDITH, M. P

“…The institution of a readily-implemented sample screening and data handling procedure for in vitro skin penetration studies yields substantial improvements in…”
Get full text

Macular pigment optical density in a midwestern sample by Ciulla, T A, Curran-Celantano, J, Cooper, D A, Hammond, Jr, B R, Danis, R P, Pratt, L M, Riccardi, K A, Filloon, T G

“…To assess the distribution of the macular pigments (MPs) lutein (L) and zeaxanthin (Z) in a healthy sample more representative of the general population than…”
Get more information

Estimating the minimum therapeutically effective dose of a compound via regression modelling and percentile estimation by Filloon, T G

“…Estimation of the minimum effective dose (MED) of a compound from a typical placebo-controlled dose-response study can be carried out in several ways. Current…”
Get more information

Randomized, Double-Blind, Placebo-Controlled, Consumer Rechallenge Test of Olean Salted Snacks by Zorich, Nora L., Biedermann, David, Riccardi, Karen A., Bishop, Lori J., Filloon, Thomas G.

“…Olestra is a zero-calorie fat substitute that is neither digested nor absorbed. A randomized, double-blind, placebo-controlled, within-subject, crossover…”
Get full text

Comparison of p-fluoroketorolac and [ 18O 3]ketorolac for use as internal standards for the determination of ketorolac by gas chromatography/mass spectrometry (GC/MS) by Eichhold, Thomas H, Filloon, Thomas G, Wehmeyer, Kenneth R

“…A chemical and a stable-isotope analog, p-fluoroketorolac and [ 18O 3]ketorolac respectively, were directly compared for applicability as internal standards…”
Get full text

Cutaneous injection of the capsaicin analogue, NE-21610, produces analgesia to heat but not to mechanical stimuli in man by Davis, Karen D, Meyer, Richard A, Turnquist, Jennifer L, Filloon, Tom G, Pappagallo, Marco, Campbell, James N

“…Intradermal injection of the capsaicin analogue, NE-21610 (Procter and Gamble), inactivates nociceptors but not low-threshold mechanoreceptors in monkey. The…”
Get more information

Cutaneous pretreatment with the capsaicin analog NE-21610 prevents the pain to a burn and subsequent hyperalgesia by Davis, Karen D, Meyer, Richard A, Turnquist, Jennifer L, Filloon, Tom G, Pappagallo, Marco, Campbell, James N

“…Cutaneous injection of the capsaicin analog NE-21610 (Procter and Gamble) produces analgesia to heat but not mechanical stimuli in humans. The present study…”
Get more information

Follow-Up to the Study: A Randomized, Double-Blind, Placebo-Controlled Consumer Rechallenge Test of Olean Salted Snacks by Zorich, Nora L., Biedermann, David, Riccardi, Karen A., Bishop, Lori J., Filloon, Thomas G.

“…Olestra is a zero-calorie fat substitute that is neither digested nor absorbed. We recently reported the results of a rechallenge study that compared the…”
Get full text

Confidence Intervals for Nonparametric Curve Estimates: Toward More Uniform Pointwise Coverage by Cummins, David J, Filloon, Tom G, Nychka, Douglas

“…Numerous nonparametric regression methods exist that yield consistent estimators of function curves. Often, one is also interested in constructing confidence…”
Get full text

Follow-up to the study: A randomized, double-blind, placebo-controlled consumer rechallenge test of Olean salted snacks by Zorich, N L, Biedermann, D, Riccardi, K A, Bishop, L J, Filloon, T G

Get full text